Abiraterone acetate: a potential source of interference in testosterone assays

Clin Chem Lab Med. 2018 May 24;56(6):e138-e140. doi: 10.1515/cclm-2017-0631.
No abstract available

Keywords: abiraterone acetate; prostate cancer; testosterone.

Publication types

  • Letter

MeSH terms

  • Abiraterone Acetate / blood*
  • Abiraterone Acetate / therapeutic use
  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / therapeutic use
  • Artifacts*
  • Cohort Studies
  • Cytochrome P-450 Enzyme Inhibitors / blood*
  • Cytochrome P-450 Enzyme Inhibitors / therapeutic use
  • Humans
  • Immunoassay
  • Limit of Detection
  • Male
  • Mass Spectrometry
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy
  • Testosterone / blood*

Substances

  • Antineoplastic Agents
  • Cytochrome P-450 Enzyme Inhibitors
  • Testosterone
  • Abiraterone Acetate